DBS: Deep brain stimulation; GPi: Globus pallidus internal; STN: Subthalamic nucleus. Although in some late-onset Parkinson's disease (PD) patients, L-Dopa-induced dyskinesia (LIDs) may be quite ...
Morning Overview on MSN
Parkinson’s breakthrough rewrites what we know about dopamine
For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...
In a recent study published in The Journal of Neuroscience, researchers at the University of Alabama at Birmingham took a different approach to dyskinesia and treated it like a “bad motor memory.” ...
Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM 2.5) and nitrogen dioxide (NO 2) was associated with a higher risk for Parkinson's disease, ...
If you have advanced Parkinson’s disease (PD), you may hear about a treatment option called vyalev (foscarbidopa/foslevodopa). It was approved by the FDA in 2024 ...
Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical messenger called dopamine. Dopamine relays signals throughout the brain ...
IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease: Gothenburg, Sweden Friday, December 26, 2025, 17:00 Hrs [IST] Sweden headquartered IRLAB, a compan ...
The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with advanced Parkinson’s disease. This novel treatment is the first of its kind, ...
Hosted on MSN
Long-term at-home adaptive deep brain stimulation found to be effective in Parkinson's disease
The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple academic medical centers and one industry partner (Medtronic) across the US, ...
Please provide your email address to receive an email when new articles are posted on . There is a need to look past dopaminergic therapy and target inflammation for disease modification. Chronic ...
Future Neurology. 2010;5(2):277-299. In this context, it is our sincere belief that a refinement of functional neurosurgery, with a less invasive approach, tailored to detect subtle neurochemical ...
Common treatments for Parkinson's disease can address short-term symptoms but can also cause extensive problems for patients in the long run. Namely, treatments can cause dyskinesia, a form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback